Ionis Pharma's drug becomes first FDA-approved treatment for rare brain disorder

◆ ◆ The Wire takeaway

Ionis Pharma's FDA approval for a rare brain disorder treatment unlocks a new niche for biotech founders chasing orphan drugs. You need to identify rare conditions overlooked by bigger players and position your product for accelerated review.